As the consumer healthcare market shifts, more scrutiny is being placed on cost of consumption of services. In a recent New York Times article Nov. 8, 2013, Good Deals on Pills? It’s Anyone’s Guess, Elisabeth Rosenthal reviews cost chaos with drugs.
For example, two popular medications for asthma and allergies, Advair and Rhinocort AQ, used by tens of thousands of Americans are no longer going to be covered by many benefit plans served by Medco/Express Scripts.
Shocked consumers will need to pay $300 and $150 respectively monthly for the brands they’re accustomed to, or find generics. In many cases, no approved generics are available.
Consumer Healthcare Cost Burden Shifting
In the past, consumers of healthcare have not been cognizant of the high cost of health care services or drugs. They presented an insurance card and rarely cared about the actual bill paid by the employer’s benefit plan.
This tradition is over, and the sticker shock over unsubsidized cost of medical and pharmaceutical prices is causing much anxiety.
A new burden is being placed on the consumer, and along with it, confusion. Read the rest of this entry »